Coherus BioSciences, Inc. earnings per share and revenue

CHRS earnings per share for the last quarter are -0.44 USD whereas the estimation was -0.31 USD which accounts for -43.99% surprise. Company revenue for the same period amounts to 54.14 M USD despite the estimated figure of 44.15 M USD. Estimated earnings per share for the next quarter are -0.30 USD, and revenue is expected to reach 54.67 M USD. Also watch annual changes over time to get a bigger picture of CHRS earnings per share and revenue dynamics.